NCT01039701 - 4 Week, Safety and Tolerability Study in Patients With Mild to Moderate Alzheimer's Disease | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 31, 2009

Primary Completion Date

July 31, 2010

Study Completion Date

July 31, 2010

Conditions

Mild to Moderate Alzheimer's Disease

Interventions

DRUG

AZD1446

capsules, oral, 3 times daily

DRUG

Placebo

capsules, oral, 3 times daily, 4 weeks

Trial Locations (12)

Research Site, Litoměřice

Research Site, Prague

Research Site, Praha 10 - Strasnice

Research Site, Debrecen

Research Site, Esztergom

Research Site, Miskolc

Research Site, Nagykálló

Research Site, Nyíregyháza

Research Site, Szeged

Research Site, Bratislava

Research Site, Rožňava

Research Site, Zlaté Moravce